Scapular Lesion Found in 27-Year-Old Man

Poll

A 27-year-old man presents with a lesion in the right scapular region. What is your diagnosis?

A 27-year-old man presents with a lesion in the right scapular region. According to the pathology slide image below, what is your diagnosis?

What is your diagnosis?

A. Leiomyosarcoma
B. Synovial sarcoma
C. Rhabdomyosarcoma
D. Neurofibroma
Recent Videos
3 experts in this video
3 experts in this video
3 experts in this video
3 experts in this video
Related Content
Real-World KRd Results Comparable to Phase 3 Trial Results in Myeloma

Real-World KRd Results Comparable to Phase 3 Trial Results in Myeloma

Tim Cortese
March 14th 2025
Article

Carfilzomib, lenalidomide, and dexamethasone results from the real world continued to show effective responses and a tolerable safety profile.

Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care

Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care

Aditya Bardia, MD, MPH;Ritu Salani, MD;Scarlett Lin Gomez, PhD;Marwan G. Fakih, MD;Elizabeth Ren Zhang-Velten, MD, PhD;Frances Chow, MD;James B. Yu, MD, MHS, FASTRO
March 10th 2025
Podcast

Hear from leading cancer experts about the lasting impact the COVID-19 pandemic has left on clinical practice.

Insight Into COVID-19’s Impact On Cancer Care: 5 Years Later

Insight Into COVID-19’s Impact On Cancer Care: 5 Years Later

Ariana Pelosci
March 14th 2025
Article

Learn how COVID-19 impacted oncology practice from the uptake of telehealth to delays in screening, with key takeaways from leading oncologists.

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Stephanie A. Berg, DO
March 7th 2025
Podcast

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

Updated Nivolumab Data Solidify Use in Advanced Gastric/GEJ/Esophageal Cancers

Updated Nivolumab Data Solidify Use in Advanced Gastric/GEJ/Esophageal Cancers

ONCOLOGY Staff
March 14th 2025
Article

Results from the CheckMate649 trial support the use of nivolumab plus chemotherapy in the treatment of advanced gastric cancers.

Durvalumab Is Not Statistically Significant Vs Cetuximab in HNSCC

Durvalumab Is Not Statistically Significant Vs Cetuximab in HNSCC

Ariana Pelosci
March 13th 2025
Article

The trial was terminated early due to no statistical significance observed between durvalumab and cetuximab for patients with head and neck squamous cell carcinoma.